Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads
Molecules · 2023
DOI: 10.3390/molecules28073189 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Tristan J Tyler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia. Hauptthemen laut MEDLINE: Peptides, Cyclic, Cyclotides. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, Australian Research Council (ARC) Centre of Excellence for Innovations in Peptide and Protein Science.
Abstract (Originalsprache)
Bioactive peptides are a highly abundant and diverse group of molecules that exhibit a wide range of structural and functional variation. Despite their immense therapeutic potential, bioactive peptides have been traditionally perceived as poor drug candidates, largely due to intrinsic shortcomings that reflect their endogenous heritage, i.e., short biological half-lives and poor cell permeability. In this review, we examine the utility of molecular engineering to insert bioactive sequences into constrained scaffolds with desired pharmaceutical properties. Applying lessons learnt from nature, we focus on molecular grafting of cyclic disulfide-rich scaffolds (naturally derived or engineered), shown to be intrinsically stable and amenable to sequence modifications, and their utility as privileged frameworks in drug design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD 4072, Australia.
ORCID-Profile: Tristan J Tyler, David J Craik
Förderung
- Australian Research Council
- National Health and Medical Research Council
- Australian Research Council (ARC) Centre of Excellence for Innovations in Peptide and Protein Science
- ARC Discovery
- NHMRC
Zitieren
APA
Tyler, T. J., Durek, T., & Craik, D. J. (2023). Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads. Molecules. https://doi.org/10.3390/molecules28073189
Vancouver
Tyler TJ, Durek T, Craik DJ. Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads. Molecules. 2023. doi:10.3390/molecules28073189
BibTeX
@article{Tyler2023,
author = {Tyler, Tristan J and Durek, Thomas and Craik, David J},
title = {Native and Engineered Cyclic Disulfide-Rich Peptides as Drug Leads},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28073189}
}
EUVIMED